Misco Products Introduces AG24 at ISSA/Interclean North America 2009
Powerful SDC-based Disinfectant Kills Influenza, Norovirus and MRSA with 24-hour Residual Protection against Staph, Pseudomonas and Salmonella
CHICACO, IL, October 6, 2009 – Misco Products introduced AG24 this week at ISSA/INTERCLEAN® North America 2009. The product launch follows the completion of an agreement with PURE Bioscience (NASDAQ: PURE), a leader in nontoxic solutions for global health challenges, for blending, packaging and distribution of PURE’s silver dihydrogen citrate SDC-based disinfectant under the name AG24™.
Ben Gable, Product Manager for Misco Products Corporation, stated, “We maintain a continuous commitment to bringing innovative products to our customers and the marketplace, and we are excited to introduce our newest disinfectant, AG24, here at ISSA as a key addition to our product line. Last year’s ISSA show brought more than 16,000 visitors, most from the janitorial supply industry, and featured more than 700 exhibitors. The jan/san commercial and institutional markets are calling for responsible products like AG24, and we believe we are positioned to fill that need. AG24 provides clear advantages and benefits with its broad spectrum efficacy, quick kill times and EPA Category IV toxicity rating. The initial response here at the trade show has been terrifically positive, and we expect our customers to quickly adopt AG24 into their inventories.”
Michael L. Krall, President and CEO of PURE Bioscience, stated, “ISSA is the largest worldwide cleaning-industry association, and its annual North America trade show, especially with the new Green Connections Center, is the premier venue for a product launch. With almost a half century of chemical manufacturing and selling experience, Misco leads the industry with a complete line of cleaning and maintenance products marketed directly and through an established and sophisticated private brand program. We are impressed with Misco’s aggressive product launch strategy and look forward to a successful relationship and expanded market reach for our SDC-based disinfectant.”
AG24 carries a 30-second kill time on Pseudomonas aeruginosa and Salmonella enterica, a 24-hour residual kill on standard indicator bacteria, a 2-minute kill time on some resistant strains of bacteria, 10-minute kill time on fungi, 30-second kill time on HIV Type I; and 3 to 10-minute kill times on other pathogenic viruses including Human and Avian Influenza A as well as Norovirus. These claims distinguish the efficacy of AG24 from many of the leading commercial and consumer products currently on the market, while maintaining lower toxicity ratings. Based on the EPA toxicity ratings from Category I (high toxicity) down to Category IV, AG24 is a Category IV antimicrobial for which hazard and precautionary labeling statements are not required. This compares with Category II warning statements for most leading brands of disinfectant products.
About Misco Products Corporation
Founded in 1962, Misco Products Corporation is located in Reading, Pennsylvania. By focusing on customer needs, MISCO has grown into a company that offers a complete line of cleaning and maintenance products and is “The Leader in Private Branding”. The mission of MISCO Products is to prosper by valuing and delighting our customers and employees through innovation, integrity and a dedication to excellence. Please visit www.miscoproducts.com.
About PURE Bioscience
PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges. PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project,” "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.